|
Market Cap (4-Jul) $8,006,598,144 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (19-Jun) 16,724,445 (4.94%) (48th) |
|
52w High $31.97 |
52w Low $17.03 |
P/E 56.82 |
EPS 0.14 |
TLX released this announcement to the ASX on 2 December 2020, 8:55. The announcement is not marked as price sensitive, and is 2 page(s) in length and 210.83kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 0.043% short sold according to ASIC data. It was ranked the 472nd most shorted stock on the ASX. It is now ranked as the 48th most shorted stock on the ASX with 4.944% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Approval for Ph I study of next generation product TLX592 | 2 December 2020, 8:55 |
| FDA Approves 68Ga-PSMA Imaging for Use at UCLA and UCSF | 2 December 2020, 8:49 |
| Briefing for Investor call - TheraPharm GmbH Acquisition | 1 December 2020, 8:23 |
| Acquisition of TheraPharm GmbH - Investor Call | 30 November 2020, 9:07 |
You must be logged in to post a reply.
Telix Pharmaceuticals 